Serotonergic innervation of the hypothalamic suprachiasmatic nucleus and photic regulation of circadian rhythms
- PMID: 9618901
- DOI: 10.1016/s0248-4900(98)80007-5
Serotonergic innervation of the hypothalamic suprachiasmatic nucleus and photic regulation of circadian rhythms
Abstract
Converging lines of evidence have firmly established that the hypothalamic suprachiasmatic nucleus (SCN) is a light-entrainable circadian oscillator in mammals, critically important for the expression of behavioral and physiological circadian rhythms. Photic information essential for the daily phase resetting of the SCN circadian clock is conveyed directly to the SCN from retinal ganglion cells via the retinohypothalamic tract. The SCN also receives a dense serotonergic innervation arising from the mesencephalic raphe. The terminal fields of retinal and serotonergic afferents within the SCN are co-extensive, and serotonergic agonists can modify the response of the SCN circadian oscillator to light. However, the functional organization and subcellular localization of 5HT receptor subtypes in the SCN are just beginning to be clarified. This information is necessary to understand the role 5HT afferents play in modulating photic input to the SCN. In this paper, we review evidence suggesting that the serotonergic modulation of retinohypothalamic neurotransmission may be achieved via at least two different cellular mechanisms: 1) a postsynaptic mechanism mediated via 5HT1A or 5ht7 receptors located on SCN neurons; and 2) a presynaptic mechanism mediated via 5HT1B receptors located on retinal axon terminals in the SCN. Activation of either of these 5HT receptor mechanisms in the SCN by specific 5HT agonists inhibits the effects of light on circadian function. We hypothesize that 5HT modulation of photic input to the SCN may serve to set the gain of the SCN circadian system to light.
Similar articles
-
5HT1B receptor agonists inhibit light-induced phase shifts of behavioral circadian rhythms and expression of the immediate-early gene c-fos in the suprachiasmatic nucleus.J Neurosci. 1996 Dec 15;16(24):8208-20. doi: 10.1523/JNEUROSCI.16-24-08208.1996. J Neurosci. 1996. PMID: 8987845 Free PMC article.
-
TFMPP, a 5HT1B receptor agonist, inhibits light-induced phase shifts of the circadian activity rhythm and c-Fos expression in the mouse suprachiasmatic nucleus.Neurosci Lett. 1997 Aug 8;231(2):95-8. doi: 10.1016/s0304-3940(97)00534-x. Neurosci Lett. 1997. PMID: 9291149
-
Serotonergic serotonin (1A) mixed agonists/antagonists elicit large-magnitude phase shifts in hamster circadian wheel-running rhythms.Neuroscience. 2003;119(2):567-76. doi: 10.1016/s0306-4522(03)00161-1. Neuroscience. 2003. PMID: 12770569
-
Serotonin and the regulation of mammalian circadian rhythmicity.Ann Med. 1999 Feb;31(1):12-33. doi: 10.3109/07853899909019259. Ann Med. 1999. PMID: 10219711 Review.
-
Photic entrainment of circadian rhythms in rodents.Chronobiol Int. 1998 Sep;15(5):395-423. doi: 10.3109/07420529808998699. Chronobiol Int. 1998. PMID: 9787933 Review.
Cited by
-
Selective pharmacological blockade of the 5-HT7 receptor attenuates light and 8-OH-DPAT induced phase shifts of mouse circadian wheel running activity.Front Behav Neurosci. 2015 Jan 15;8:453. doi: 10.3389/fnbeh.2014.00453. eCollection 2014. Front Behav Neurosci. 2015. PMID: 25642174 Free PMC article.
-
Circadian and dark-pulse activation of orexin/hypocretin neurons.Mol Brain. 2008 Dec 3;1:19. doi: 10.1186/1756-6606-1-19. Mol Brain. 2008. PMID: 19055781 Free PMC article.
-
Setting the main circadian clock of a diurnal mammal by hypocaloric feeding.J Physiol. 2012 Jul 1;590(13):3155-68. doi: 10.1113/jphysiol.2012.230300. Epub 2012 May 8. J Physiol. 2012. PMID: 22570380 Free PMC article.
-
Brain Dopamine-Clock Interactions Regulate Cardiometabolic Physiology: Mechanisms of the Observed Cardioprotective Effects of Circadian-Timed Bromocriptine-QR Therapy in Type 2 Diabetes Subjects.Int J Mol Sci. 2023 Aug 26;24(17):13255. doi: 10.3390/ijms241713255. Int J Mol Sci. 2023. PMID: 37686060 Free PMC article. Review.
-
The neuropeptide Y Y5 receptor mediates the blockade of "photic-like" NMDA-induced phase shifts in the golden hamster.J Neurosci. 2001 Jul 15;21(14):5367-73. doi: 10.1523/JNEUROSCI.21-14-05367.2001. J Neurosci. 2001. PMID: 11438613 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources